Cell Signaling and Drug Discovery Group (Waaler)
Biotechnology Research
Oslo, No
6 employees
IMMX
- Employees
- 6
Cell Signaling and Drug Discovery Group (Waaler) Overview
- Headquarters
- Oslo, No
- Website
- www.ous-research.no
- Industry
- Biotechnology Research
- Employees
- 6
- Stock Symbol
- IMMX
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
About Cell Signaling and Drug Discovery Group (Waaler)
Our research group at Oslo University Hospital is dedicated to advancing the understanding of tankyrase 1 and tankyrase 2 (TNKS1/2), key enzymes in the PARP family that regulate protein function, interactions, and degradation through ADP-ribosylation and downstream signaling. TNKS1/2 play crucial roles in controlling WNT/β-catenin and Hippo signaling pathways, both of which are central to disease mechanisms such as cancer, immune evasion, and fibrosis.
Compare Similar Companies to Cell Signaling and Drug Discovery Group (Waaler)
Syneos Health
Biotechnology Research
Miltenyi Biotec
Biotechnology Research
Parse Biosciences
Biotechnology Research
Norwegian Centre for Molecular Biosciences and Medicine (NCMBM), University of Oslo
Research
Scale Biosciences
Biotechnology Research
Libertad Con Ciencia
Higher Education
PL BioScience GmbH
Biotechnology
Immix Biopharma (Nasdaq: IMMX)
Biotechnology
CRESCO - Centre For Embryology and Healthy Development
Biotechnology Research
Odin Therapeutics
Pharmaceutical Manufacturing